
501 - 1000 employees
Founded 2014
🏥 Healthcare
🧬 Biotechnology
đź’Š Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Iovance Biotherapeutics, Inc. is pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and attack diverse cancer cells in each patient. The company focuses on T-cell-based immunotherapy, specifically Tumor Infiltrating Lymphocyte (TIL) therapy, which involves reinvigorating a patient’s TILs to fight cancer. Iovance's TIL therapy is being investigated in clinical trials across multiple advanced solid tumor cancers. Additionally, the company is advancing genetically modified TIL therapies and exploring potential applications of PBL (peripheral blood lymphocyte) therapy for blood cancers. As a leader in cell therapy, Iovance owns a state-of-the-art Cell Therapy Center in Philadelphia for manufacturing their therapies using proprietary GMP. The company is at the forefront of developing personalized and patient-specific cancer treatments.
🔥 0 minutes ago
🇺🇸 United States – Remote
đź’µ $185k - $205k / year
⏰ Full Time
đźź Senior
đź‘” Director
đź‘» Ghost score 0%
Where this job comes from
Posted on Iovance Biotherapeutics, Inc.'s careers page, not through a job board
First seen by Remote Rocketship 0 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

501 - 1000 employees
Founded 2014
🏥 Healthcare
🧬 Biotechnology
đź’Š Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Iovance Biotherapeutics, Inc. is pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and attack diverse cancer cells in each patient. The company focuses on T-cell-based immunotherapy, specifically Tumor Infiltrating Lymphocyte (TIL) therapy, which involves reinvigorating a patient’s TILs to fight cancer. Iovance's TIL therapy is being investigated in clinical trials across multiple advanced solid tumor cancers. Additionally, the company is advancing genetically modified TIL therapies and exploring potential applications of PBL (peripheral blood lymphocyte) therapy for blood cancers. As a leader in cell therapy, Iovance owns a state-of-the-art Cell Therapy Center in Philadelphia for manufacturing their therapies using proprietary GMP. The company is at the forefront of developing personalized and patient-specific cancer treatments.
• Serve as a subject matter expert and internal liaison for assigned therapeutic areas • Support and facilitate comprehensive cross-functional global publication planning • Generate and execute annual publication plans and support presence at scientific congresses • Identify and prioritize regional and local publication needs • Partner with agency partners to deliver accurate and appropriate publications on time, within budget, and according to policy • Partner with the Scientific Communications lead to incorporate published data into medical materials • Ensure publication processes and materials comply with Iovance policies and guidelines, including ICMJE, PhRMA, and GPP • Leverage best practices and implement efficient publication processes across Medical Affairs • Support execution and implementation of iEnvision for publications management • Adhere to Iovance core values, policies, procedures, and business ethics • Perform miscellaneous duties as assigned • Collaborate with Clinical Development, HEOR, Biometrics, preclinical, and research teams • Engage healthcare professional experts and authors
• Advanced scientific/clinical degree required (e.g., PharmD, Ph.D., MD) in a science-related field • 10+ years relevant industry experience in medical/scientific publications for advanced scientific/clinical degree candidates • Master’s degree in a science-related field with 12+ years relevant industry experience • Experience in Cell Therapy or IO • Experience developing and medically writing peer-reviewed publications and congress materials, including abstracts, posters, and presentations • Experience with publication management systems such as Datavision required • Strong HEOR experience required • Experience with publication planning and execution, including literature gap analysis • Excellent communication, organizational, and time management skills • Experience developing scientific communication platforms or scientific statements • Experience in literature searches, literature evaluation, drug information, and educational concepts • Ability to remain stationary for extended periods • Ability to move within an office or remote workspace and occasionally exert up to 10 pounds of force • Visual acuity for preparing and analyzing data, viewing computer screens, and extensive reading • Repetitive wrist, hand, and/or finger motion • Ability to communicate effectively • Ability to perform analytical, conceptual, and problem-solving activities • Clear and conceptual thinking, judgment, troubleshooting, discretion, stress management, prioritization, and deadline management
• Reasonable accommodation may be provided to enable individuals to perform required functions • Professional or remote office environment • Equal-opportunity employment and application assistance/accommodation
Apply Now🔥 58 minutes ago
Senior Director leading identity cybersecurity technical sales strategy at Palo Alto Networks. Advising strategic customers and shaping technical go-to-market execution across the US Central region.
🇺🇸 United States – Remote
đź’° $1M Seed Round - Morta Security on 2013-02
⏰ Full Time
đźź Senior
đź‘” Director
🦅 H1B Visa Sponsor
🔥 1 hour ago
Associate Director guiding HAE market insights, analytics, and forecasting for Ionis RNA-targeted medicines. Translating research and competitive intelligence into brand strategy and growth recommendations.
🔥 1 hour ago
Associate Director guiding HAE market insights, brand health, research, and forecasting for Ionis Pharmaceuticals’ RNA-targeted medicines. Translating analytics into rare-disease growth strategies.
🔥 1 hour ago
Associate Director strengthening primary health systems for Lilly’s diabetes and obesity initiatives. Leading global partnerships, measurement, policy, digital infrastructure, and impact programs in resource-limited settings.
🇺🇸 United States – Remote
đź’µ $136.5k - $200.2k / year
đź’° $6.5M Post-IPO Debt - Eli Lilly on 2024-02
⏰ Full Time
đźź Senior
đź‘” Director
🔥 7 hours ago
Associate Director transitioning IREN’s renewable-powered AI cloud data centers from commissioning into operations. Governing readiness, maintenance standards, KPIs, audits, and fleet reliability.